UniProtKB/Swiss-Prot P35499: Variant p.Ser524Gly

Sodium channel protein type 4 subunit alpha
Gene: SCN4A
Feedback?

Variant information Variant position:

524 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Serine (S) to Glycine (G) at position 524 (S524G, p.Ser524Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from small size and polar (S) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs6504191 [ dbSNP | Ensembl ]

Sequence information Variant position:

524 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

1836 The length of the canonical sequence.
Location on the sequence:

KDCNGSLDTSQGEKGAPRQS S SGDSGISDAMEELEEAHQKC The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         KDCNGSLDTSQGEKGAPRQSSSGDSGISDAMEELEEAHQKC

Mouse                         KDCNGSLDTS-GEKGPPRPSCSAESAISDAMEELEEAHQKC

Rat                           KDCNGSLDAS-GEKGPPRPSCSADSAISDAMEELEEAHQKC

Horse                         KDCNGSLDTSPGEKGPPRQSCSADSGVSDAMEELEEAHQKC

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 1836	Sodium channel protein type 4 subunit alpha
Topological domain	445 – 578	Cytoplasmic
Region	493 – 530	Disordered
Compositional bias	507 – 530	Polar residues

Literature citations
Primary structure of the adult human skeletal muscle voltage-dependent sodium channel.
George A.L. Jr.; Komisarof J.; Kallen R.G.; Barchi R.L.;
Ann. Neurol. 31:131-137(1992)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]; VARIANTS GLY-524; ASP-559 AND ASP-1376; Myasthenic syndrome caused by mutation of the SCN4A sodium channel.
Tsujino A.; Maertens C.; Ohno K.; Shen X.-M.; Fukuda T.; Harper C.M.; Cannon S.C.; Engel A.G.;
Proc. Natl. Acad. Sci. U.S.A. 100:7377-7382(2003)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; FUNCTION; TRANSPORTER ACTIVITY; SUBCELLULAR LOCATION; VARIANT CMS16 GLU-1442; VARIANTS LEU-246; GLY-524 AND ASP-559; CHARACTERIZATION OF VARIANT CMS16 GLU-1442; CHARACTERIZATION OF VARIANT LEU-246; The genomic structure of the human skeletal muscle sodium channel gene.
McClatchey A.I.; Lin C.S.; Wang J.; Hoffman E.P.; Rojas C.V.; Gusella J.F.;
Hum. Mol. Genet. 1:521-527(1992)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANT GLY-524;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.